Kookmin Bio Co., Ltd.

Kookmin Bio Co., Ltd.

Private
JeonjuHealthcare & Life Scienceshttps://kmbio.co.kr/ko/

Last Round

Series B

Nov 20, 2024

Total Funding Raised

$4.58M

Company Overview

Kookmin Bio Co., Ltd. is a biotechnology company that researches and develops bio-based food and pharmaceutical ingredients and microbiome-based new drugs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Drug Discovery, Clinical Trials, Sports & Fitness

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

postbioticsmicrobiome modulationfunctional foodsnutraceuticalssarcopenia treatmentobesity treatmentmicrobiome therapeuticsdrug discoverygut healthB2B ingredientsfermentation technologybiopharmaKorean fermented foodsclinical trialshealth functional foodsGMP manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kookmin Bio Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kookmin Bio Co., Ltd. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BNov 20, 2024
Series AMay 20, 2022
Pre SeedNov 19, 2021

Kookmin Bio Co., Ltd. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 20, 2024

    $3M round led by New Paradigm Investment.

  • May 20, 2022

    $1.58M round led by New Paradigm Investment.

Kookmin Bio Co., Ltd. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kookmin Bio Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kookmin Bio Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersJeonju
Year Founded2019
Last FundingNov 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.